CYP19A1 and breast cancer: In fact, some aromatase inhibitors (AIs) - like letrozole, for example, which has been approved for the treatment of breast cancer by the Food and Drug Administration (FDA) [6] - have been clinically successful in treating epilepsy in men [7].